Mads Hald Andersen

44PUBLICATIONS

148CO-AUTHORS

Tissue engineeringApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Transplantation immunologyPredictive and prognostic markersGene and molecular therapy

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (44)

Sort by Publication Date:

|Jun 23, 2026

Engineering T cells with a novel PD-L1-specific TCR targeting immune and cancer cells.

|Apr 10, 2026

Immune modulatory vaccines targeting tumor microenvironment antigens: recent advances in oncology and beyond.

Mads Hald Andersen

|Apr 08, 2026

Immune reconstitution in patients with myelofibrosis conditioned with a non-myeloablative regimen prior to allogeneic stem cell transplantation.

Morten Orebo Holmström, Lia Minculescu, Katrine Nørgaard

|Mar 24, 2026

Rationale for multi-epitope TGFβ vaccination in pancreatic cancer: evidence from immunologic and clinical correlates.

Josephine Hallundbæk Ruders, Shamaila Munir Ahmad, Rasmus Erik Johansson Mortensen

|Dec 14, 2025

Five-year clinical outcome and immune biomarkers of durable response from the MM1636 trial on IDO/PD-L1 vaccination and PD-1 blockade in first line metastatic melanoma.

Sidsel Pedersen, Mikkel Byrdal, Evelina Martinenaite

|Nov 17, 2025

β-adrenergic signaling blockade attenuates metastasis through activation of cytotoxic CD4 T cells.

Klaire Yixin Fjæstad, Astrid Zedlitz Johansen, Hannes Linder

Pageof 8

Frequent Collaborators

9 joint publications

Morten Orebo Holmström

Inge Marie Svane

Maria Perez-Penco

Özcan Met

Hans Hasselbalch

Marco Donia

Jürgen C Becker

Maria Gluud

Andreas Willerslev-Olsen

3 joint publications

Terkild Brink Buus

Frequent Collaborators

9 joint publications

Morten Orebo Holmström

9 joint publications

Inge Marie Svane

7 joint publications

Maria Perez-Penco

5 joint publications

Özcan Met